| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/11/2004 | WO2004020594A2 Solanum bulbocastanum late blight resistance gene and use thereof |
| 03/11/2004 | WO2004020589A2 The gene for a dof transcription factor capable of altering the size and stature of a plant |
| 03/11/2004 | WO2004020588A2 Transferrin fusion protein libraries |
| 03/11/2004 | WO2004020585A2 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 03/11/2004 | WO2004020580A2 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 03/11/2004 | WO2004020579A2 Method of humanizing immune system molecules |
| 03/11/2004 | WO2004020577A2 Processes for inhibiting gene expression using polynucleotides |
| 03/11/2004 | WO2004020575A2 Methods and systems for detection and isolation of a nucleotide sequence |
| 03/11/2004 | WO2004020468A2 Interferon beta-like molecules for treatment of cancer |
| 03/11/2004 | WO2004020465A2 Proteins involved in the regulation of energy homeostasis |
| 03/11/2004 | WO2004020404A2 Modified transferin-antibody fusion proteins |
| 03/11/2004 | WO2004020085A1 High density arrays |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019968A1 Methods for preserving organs and tissues |
| 03/11/2004 | WO2004019893A2 Modulators of angiogenesis |
| 03/11/2004 | WO2004019890A2 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 03/11/2004 | WO2004019879A2 Motilide compounds |
| 03/11/2004 | WO2004019878A2 Adzymes and uses thereof |
| 03/11/2004 | WO2004019864A2 Quantitative rt-pcr to ac133 to diagnose cancer and monitor angiogenic activity in a cell sample |
| 03/11/2004 | WO2004019676A2 Animal model for perimenopause and menopause and methods of inducing ovarian failure |
| 03/11/2004 | WO2004009820A8 Method for obtaining the pathogenic resistance in plants |
| 03/11/2004 | WO2004009815A3 Silencing hybrid gene expression |
| 03/11/2004 | WO2004007767A3 Serrs reactive particles |
| 03/11/2004 | WO2004007537A3 Modified adenoviral fiber with ablated to cellular receptors |
| 03/11/2004 | WO2004007525A3 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 03/11/2004 | WO2004003231A3 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 03/11/2004 | WO2004003217A8 Glutathione production |
| 03/11/2004 | WO2004000882A3 Proteins |
| 03/11/2004 | WO2003106618A3 Cancer therapy by modulating cdc42-activity |
| 03/11/2004 | WO2003104251A9 Composition and methods for obtaining nucleic acids from sputum |
| 03/11/2004 | WO2003095480A3 Brachyspira hyodysenteriae vaccine |
| 03/11/2004 | WO2003093506A3 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis |
| 03/11/2004 | WO2003093449A3 Methods for delivery of nucleic acids |
| 03/11/2004 | WO2003092630A3 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 03/11/2004 | WO2003091396A3 Polypeptides and biosynthetic pathways |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003078650A3 Manganese ion regulation of reverse transcriptase activity and methods of modulating same |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003074563A3 Means and methods for manipulating hypersensitivity-like responses |
| 03/11/2004 | WO2003072790A3 Production of dadzein in transgenic plants |
| 03/11/2004 | WO2003071860A3 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage |
| 03/11/2004 | WO2003071268A3 Method for discovering pharmacologically active substances |
| 03/11/2004 | WO2003070966A3 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/11/2004 | WO2003068933A3 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003064993A3 Methods and materials for detecting genetic material |
| 03/11/2004 | WO2003062410A3 Torero protein |
| 03/11/2004 | WO2003060135A3 Use of a wdv promoter for phloem-specific expression |
| 03/11/2004 | WO2003059395A3 Antisense compounds directed against human csf-1 |
| 03/11/2004 | WO2003056010A3 An antisense strategy to modulate estrogen receptor response (er. alpha. and/or er. beta.) |
| 03/11/2004 | WO2003055974A3 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 03/11/2004 | WO2003055908A3 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003047532A3 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition |
| 03/11/2004 | WO2003046183A3 Streptococcus suis avirulent vaccine and uses in antibiotic design |
| 03/11/2004 | WO2003046007A3 Treatment of micro-organism infection |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003040337A3 Polyamide modulators of cox2 transcription |
| 03/11/2004 | WO2003038436A3 Microfluidic ser(r)s detection |
| 03/11/2004 | WO2003037368A3 Smad7 inhibitors for the treatment of cns diseases |
| 03/11/2004 | WO2003035878A3 Lipase variants |
| 03/11/2004 | WO2003035826A3 Genetic screening methods |
| 03/11/2004 | WO2003031603A8 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/11/2004 | WO2003030639A3 Methods for growing and imprinting fish using an odorant |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003027260A3 Methods and compositions for generating homozygous mutations |
| 03/11/2004 | WO2003027229A3 Antisense modulation of rip2 expression |
| 03/11/2004 | WO2003025116A3 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/11/2004 | WO2003024384A3 Improved methods for treatment with viral vectors |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003018771A3 A system for antibody expression and assembly |
| 03/11/2004 | WO2003016498A3 Molecular interaction sites of rnase p rna and methods of modulating the same |
| 03/11/2004 | WO2003015500A3 Methods for the identification of inhibitors of phytochrome e expression or activity in plants |
| 03/11/2004 | WO2003014306A3 Antisense modulation of cholesteryl ester transfer protein expression |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003012393A3 Method of detecting protease activity in a cell |
| 03/11/2004 | WO2003012100A3 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2003006608A3 Enhancement of transfection of dna into the liver |
| 03/11/2004 | WO2003004646A3 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 03/11/2004 | WO2003004600A3 Improvement of viral uptake into cells and tissues |
| 03/11/2004 | WO2002101026A8 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 03/11/2004 | WO2002099063A8 Alteration of embryo/endosperm size during seed development |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002096349A3 Vaccination against the feline immunodeficiency virus |
| 03/11/2004 | WO2002095068A3 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 03/11/2004 | WO2002094008A3 Transgenic plants protected against parasitic plants |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002083074A3 Methods for the treatment of hepatic disorders |
| 03/11/2004 | WO2002081654A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002079434A3 Transgenic mice containing kir3.3 potassium channel gene disruptions |
| 03/11/2004 | WO2002079426A3 Transgenic mice containing pai3 serine protease inhibitor gene disruptions |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | WO2002070661A3 Identification and characterization of a waxy curled leaf phenotype (wcl1) in arabidopsis |
| 03/11/2004 | WO2002068602A3 Methods for modulating g2a receptor activity |
| 03/11/2004 | WO2002062135A8 Scce modified transgenic mammals and their use as models of human disease |
| 03/11/2004 | WO2002060923A3 B-superfamily conotoxins |
| 03/11/2004 | US20040049819 Soybean cultivar SN83544 |
| 03/11/2004 | US20040049818 Producing a soybean plant produced by crossing the cultivar with itself or another soybean variety; hybrid soybean seeds and plants produced by crossing the cultivar and another cultivar |